
### [NCIT:C9283](http://purl.obolibrary.org/obo/NCIT_C9283)
**Label:** Lymphocyte-Depleted Classical Hodgkin Lymphoma

**Subclasses:** [NCIT:C8649](http://purl.obolibrary.org/obo/NCIT_C8649) (Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8061](http://purl.obolibrary.org/obo/NCIT_C8061) (Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C5067](http://purl.obolibrary.org/obo/NCIT_C5067) (Stage II Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C9125](http://purl.obolibrary.org/obo/NCIT_C9125) (Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8650](http://purl.obolibrary.org/obo/NCIT_C8650) (Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8651](http://purl.obolibrary.org/obo/NCIT_C8651) (Stage IV Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C3583](http://purl.obolibrary.org/obo/NCIT_C3583) (Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C5064](http://purl.obolibrary.org/obo/NCIT_C5064) (Stage I Lymphocyte-Depleted Classical Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.80%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 36.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 36.74%


